80 FR 106 pgs. 31601-31602 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements
Type: NOTICEVolume: 80Number: 106Pages: 31601 - 31602
Pages: 31601, 31602Docket number: [Docket No. FDA-2014-N-0168]
FR document: [FR Doc. 2015-13473 Filed 6-2-15; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-0168]
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing that a collection of information entitled, "Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
[top] On January 15, 2015, the Agency submitted a proposed collection of information entitled, "Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements" to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control
Dated: May 29, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-13473 Filed 6-2-15; 8:45 am]
BILLING CODE 4164-01-P